Nucor Analysts Chase Targets Higher Ahead of Q4 Print

Nucor reports Q4 results on November 5, riding a 16% share price gain over the past month to $273.87, with Wall Street's price targets still playing catch-up to a stock that has outpaced most of its peers.

The analyst revision wave is the defining feature of the setup. JP Morgan raised its target to $304 on October 28, maintaining Overweight. Barclays went further, lifting to $320 from $306 the same day, the highest target among recent moves. Wells Fargo also raised on October 28, moving to $305 from $280. The consensus mean now stands at $293.56, still roughly 7% above the current price, which is notable given how far NUE has already moved. Freedom Broker upgraded outright on October 30, shifting from Hold to Buy with a $304 target. EPS momentum ranks in the 87th percentile on a 30-day basis and the 84th over 90 days, pointing to a sustained run of estimate upgrades, not just a one-off reaction to the Q3 beat.

Options positioning has turned more defensive than it was heading into the Q3 print. The put/call ratio is now 0.82, above its 20-day average of 0.79, a reversal from the call-heavy tilt that preceded the October earnings release. That is still well inside the 52-week high of 0.87, so the shift is a modest caution rather than outright fear, but it marks a clear contrast with the bullish options posture that proved correct last quarter. Short interest, at 2.1% of the free float, has risen about 12.6% over the past week. That is a statistically unusual move: this week's increase is running roughly 2.2 standard deviations above Nucor's typical weekly short interest change over the past year. Even so, the borrow market remains entirely open with shares available to lend far exceeding what is borrowed, and borrowing cost is still just 0.42%, so the increase looks more like selective positioning than a conviction short thesis.

The insider picture adds a counterweight to the bullish analyst tone. Over the past 90 days, insiders have been net sellers of roughly $11.6 million in stock, with an EVP selling $1.4 million on October 29, just days before the print. None of the trades appear to be under 10b5-1 plans. The open-market sales are modest in the context of the company's $62 billion market cap, but the direction matters: executives are trimming into strength rather than adding. Berkshire Hathaway also cut its position by over 2 million shares in its last reported period, reducing a stake that had previously been a closely watched signal for the steel sector.

NUE's Q4 print will test whether the earnings momentum that drove a 5% gain after Q3 results can hold against a more cautious options market, rising short interest, and a management team that has been using the rally to reduce its own exposure.